Intravitreal vascular endothelial growth factor inhibition associates with decreased risk of all-cause mortality in patients with neovascular aged-related degeneration

Benjamin Sommer Thinggaard; Yousif Subhi; Sören Möller; Ryo Kawasaki; Jakob Grauslund; Lonny Stokholm

Intravitreal vascular endothelial growth factor inhibition associates with decreased risk of all-cause mortality in patients with neovascular aged-related degeneration

University of Osaka

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	463
Journal	Investigative Ophthalmology & Visual Science
Volume	64
Issue number	8
Publication status	Published - Jun 2023
Event	ARVO 2023 - New Orleans, United States Duration: 23. Apr 2023 → 27. Apr 2023

Conference

Conference	ARVO 2023
Location	New Orleans
Country/Territory	United States
Period	23/04/2023 → 27/04/2023

Documents & Links

https://iovs.arvojournals.org/article.aspx?articleid=2785793Licence: CC BY-NC-ND

SDU Link

Check access to the material in SDU Library's search engine

Cite this

Sommer Thinggaard, B., Subhi, Y., Möller, S., Kawasaki, R., Grauslund, J., & Stokholm, L. (2023). Intravitreal vascular endothelial growth factor inhibition associates with decreased risk of all-cause mortality in patients with neovascular aged-related degeneration. Investigative Ophthalmology & Visual Science, 64(8), Article 463. https://iovs.arvojournals.org/article.aspx?articleid=2785793

@article{0e21dd3d1ad44d80b4f2be72ecc9b569,

title = "Intravitreal vascular endothelial growth factor inhibition associates with decreased risk of all-cause mortality in patients with neovascular aged-related degeneration",

author = "\{Sommer Thinggaard\}, Benjamin and Yousif Subhi and S{\"o}ren M{\"o}ller and Ryo Kawasaki and Jakob Grauslund and Lonny Stokholm",

year = "2023",

month = jun,

language = "English",

volume = "64",

journal = "Investigative Ophthalmology \& Visual Science",

number = "8",

note = "ARVO 2023 ; Conference date: 23-04-2023 Through 27-04-2023",

}

Sommer Thinggaard, B , Subhi, Y , Möller, S, Kawasaki, R, Grauslund, J & Stokholm, L 2023, 'Intravitreal vascular endothelial growth factor inhibition associates with decreased risk of all-cause mortality in patients with neovascular aged-related degeneration', Investigative Ophthalmology & Visual Science, vol. 64, no. 8, 463. <https://iovs.arvojournals.org/article.aspx?articleid=2785793>

Intravitreal vascular endothelial growth factor inhibition associates with decreased risk of all-cause mortality in patients with neovascular aged-related degeneration. / Sommer Thinggaard, Benjamin ; Subhi, Yousif ; Möller, Sören et al.
In: Investigative Ophthalmology & Visual Science, Vol. 64, No. 8, 463, 06.2023.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Intravitreal vascular endothelial growth factor inhibition associates with decreased risk of all-cause mortality in patients with neovascular aged-related degeneration

AU - Sommer Thinggaard, Benjamin

AU - Subhi, Yousif

AU - Möller, Sören

AU - Kawasaki, Ryo

AU - Grauslund, Jakob

AU - Stokholm, Lonny

PY - 2023/6

Y1 - 2023/6

M3 - Conference abstract in journal

VL - 64

JO - Investigative Ophthalmology & Visual Science

JF - Investigative Ophthalmology & Visual Science

IS - 8

M1 - 463

T2 - ARVO 2023

Y2 - 23 April 2023 through 27 April 2023

ER -